-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905. Outcomes Research—Lymphoid Malignancies: Poster II

Symposia: Outcomes Research—Lymphoid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Samuel Sassine, MD, MSc1*, Marie-Claude Pelland-Marcotte, MD, PhD2, André Ilinca3*, Uma Athale, MD, MBBS, MSc4, Henrique Bittencourt3, Lynette Bowes, MD5*, Josée Brossard, MD6*, Sara J. Israels, MD7, Johnston Donna, MD8*, Ketan Kulkarni, MD9, Sarah McKillop, MD10*, Meera Rayar, MD11*, Roona Sinha, MD12*, Tony Truong, MD13*, Catherine Vezina, MD14*, Laura Wheaton, MD15*, Alexandra Zorzi16*, Lillian Sung, MD, PhD17 and Thai Hoa Tran, MD1

1CHU Sainte-Justine, Montreal, QC, Canada
2CHU de Québec - Centre Mère-Enfant Soleil, Québec, QC, Canada
3CHU Sainte-Justine, Montreal, Canada
4McMaster University Div. of Pediatric Hematology/Oncology, Hamilton, ON, CAN
5Janeway Child Health & Rehab. Ctr., St. John's, NL, CAN
6CHU de Sherbrooke, Sherbrooke, QC, CAN
7CancerCare Manitoba, Winnipeg, MB, CAN
8Children's Hospital of Eastern Ontario, Ottawa, Canada
9IWK Health Center, Halifax, NS, Canada
10Stollery Children's Hospital, Edmonton, Canada
11BC Children's Hospital, Vancouver, Canada
12Jim Pattison Children's Hospital, Saskatoon, SK, CAN
13Alberta Children's Hospital, Calgary, Canada
14McGill University, Montreal, QC, Canada
15Kingston Health Sciences Centre, Kingston, Canada
16London Health Sciences Centre, London, Canada
17The Hospital for Sick Children, Toronto, ON, Canada

Mazie Tsang, MD1, Brie N. Noble, MS2*, Côme Bommier, MD, MSc3*, Carla Casulo, MD4, Carrie Thompson, MD, MS5, Allison C. Rosenthal, DO6, Dai Chihara, MD, PhD7, Eric Mou, MD8*, Urshila Durani, MD, MPH5, Annalynn M Williams, PhD, MS9, Michelle Hildebrandt, PhD10, Kathleen Yost, PhD11*, Melissa C. Larson, MS12*, Brianna Gysbers13*, Matthew J. Maurer, DSc13, Susan L. Slager, PhD14, Andrew L. Feldman, MD15, David L Jaye, MD16, Jon Tilburt, MD, MPH2*, J. C. C. Villasboas, MD17*, Ajay Major, MD, MBA18, Priyanka A Pophali, MD19, Talal Hilal, MD1, Yucai Wang, MD, PhD5, Timothy G. Call, MD5, Amber Koehler, PA-C20*, Javier L. Munoz21, Gita Thanarajasingam, MD5, Paul J Hampel, MD5, Sameer A. Parikh, MD22, Loretta J. Nastoupil, MD23, Thomas E. Witzig, MD17, Grzegorz S. Nowakowski, MD5, Stephen M Ansell, MD, PhD5, Jonathon B. Cohen, MD, MS24, Thomas M. Habermann, MD5, Christopher Strouse, MD25, Izidore S. Lossos, MD26, Brad S. Kahl, MD27, Peter Martin, MD28, Christopher R. Flowers, MD, MS7, James R. Cerhan, MD, PhD14 and Amylou Constance Dueck, PhD2

1Mayo Clinic, Phoenix, AZ
2Mayo Clinic, Scottsdale, AZ
3Division of Epidemiology, Mayo Clinic, Rochester, MN
4Wilmot Cancer Center, University of Rochester, Rochester, NY
5Division of Hematology, Mayo Clinic, Rochester, MN
6Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
7Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
8Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
9James P. Wilmot Cancer Institute, University of Rochester Medical Center, Fairport, NY
10The University of Texas MD Anderson Cancer Center, Houston, TX
11Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
12Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, MN
13Department of Health Sciences Research, Mayo Clinic, Rochester, MN
14Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
15Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN
16Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA
17Mayo Clinic, Rochester, MN
18The University of Chicago Comprehensive Cancer Center, Denver, CO
19Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
20Division of Hematology, Department of Medicine, Mayo Clinic, Rochester
21Department of Hematology, Mayo Clinic, Phoenix, AZ
22Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
23MD Anderson Cancer Center, Houston, TX
24Winship Cancer Institute, Emory University, Atlanta, GA
25Division of Hematology, Oncology and Blood & Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA
26Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL
27School of Medicine, Washington University in St. Louis, St Louis, MO
28Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY

Paul Saultier1*, Gerard Michel, MD2*, Anne Sirvent, MD3*, Carine Halfon-Domenech4*, Marie-Dominique Tabone5*, Guy Leverger, MD, PhD6*, Andre Baruchel, MD7, Cecile Pochon8*, Catherine Paillard9*, Stephane Ducassou, MD, PhD10*, Marilyne Poiree11*, Dominique Plantaz12*, Justyna Kanold13*, Virginie Gandemer14*, Nicolas Sirvent15*, Nicole Raus16*, Sandrine Thouvenin17*, Julie Berbis2*, Pascal Auquier18* and Jean-Hugues Dalle19*

1APHM, Marseille, France
2APHM, Marseille, FRA
3CHU Montpellier, Montpellier, France
4Institut D'Hématologie Et D'Oncologie Pédiatrique, LYON, FRA
5APHP, Paris, France
6Hôpital Trousseau, Paris, France
7Hôpital Robert Debré, Paris, France
8Department of Hematology, Centre Hospitalier Régional Universitaire (CHRU), Vandoeuvre-les-Nancy, France
9CHRU Strasbourg, Strasbourg, FRA
10Service d'onco-hématologie pédiatrique, Hôpital Pellegrin Tripode, Bordeaux, FRA
11CHU Nice, Nice, FRA
12CHU Grenoble, Grenoble, France
13CHU Clermont Ferrand, Clermontferrand, FRA
14CHU Hopital Sud, Rennes, FRA
15CHU MONTPELLIER, MONTPELLIER, FRA
16Hôpital Edouard Herriot, Lyon, FRA
17CHU Saint Etienne, Saint Etienne, FRA
18Aix-Marseille University, MARSEILLE, FRA
19Department of Pediatric Hematology and Immunology, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France

Carmelo Rizzari, MD1*, Nicolás Tentoni, MD2,3*, Ryan Combs, CFA2*, Jennifer Lowe, MSc2*, Miriam Hwang, MD2*, Thais Murciano, MD4*, María Dolores Aumente, PharmD5*, Teresa López-Viñau López, PharmD5* and Scott C. Howard, MD, MSc2,6

1Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
2Resonance, Memphis, TN
3Laboratory of Applied Statistics in the Health Sciences, University of Buenos Aires, School of Medicine, Buenos Aires, Argentina
4Pediatric Oncology and Hematology Service, Vall d’Hebron University Hospital, Barcelona, Spain
5Pharmacy Service, Reina Sofia University Hospital/Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/University of Córdoba, Córdoba, Spain
6Sant Joan de Déu Hospital, Barcelona, Spain

Kylee H Maclachlan, MBChB, PhD1, Patrick Blaney, MS2,3*, Anthony Cirrincione, PhD4*, Timothy R. Chu, MS5*, Alexandra Maria Poos, PhD6*, Elizabeth E. Brown, PhD, MPH7, Elisabet E. Manasanch, MD8, Antje Hoering, PhD9, Liming Hou, PhD2*, Dylan Gagler, B.S.2,3*, Yubao Wang, PhD2*, Sanxiong Liu, PhD2*, Benjamin Diamond, MD4, Bachisio Ziccheddu4*, Marc S. Raab6*, Niels Weinhold, PhD6*, Ola Landgren, MD4, Nicolas Robine, PhD5*, Faith E. Davies, MD2, Alexander Lesokhin, MD10, Saad Z Usmani, MD11, Francesco Maura, MD12 and Gareth J. Morgan, M.D., Ph.D.2*

1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Perlmutter Cancer Center, Multiple Myeloma Research Program, NYU Grossman School of Medicine, NYU Langone Health, New York, NY
3Applied Bioinformatics Laboratories, NYU Grossman School of Medicine, NYU Langone Health, New York, NY
4Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL
5New York Genome Center, New York, NY
6Heidelberg Myeloma Center, Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
7O’Neal Comprehensive Cancer Center, University of Alabama At Birmingham, Birmingham, AL
8Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
9Cancer Research And Biostatistics, Seattle, WA
10Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY
11Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
12Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, PALMETTO BAY, FL

Mustafa Wasifuddin, MD1*, Nosakhare Paul Ilerhunmwuwa, MBBS, MSc1, Henry Becerra, MD1*, Narek Hakobyan1*, Ifeanyi Nnamdi Uche, MBBS1, Ruchi Yadav, MD2*, Akriti Pokhrel2*, Jin Zheng2*, Hesham Ali Abowali, MD2, Omid Heravi, MD2, Beka Aroshidze, MD2, Ladan Enayati, MD2*, Kapilkumar Manvar, MD2*, Dosbai Saparov1*, Siddharth Yadav3* and Jen-Chin Wang, MD4

1Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY
2Division of Hematology/Oncology, Brookdale University Hospital and Medical Center, Brooklyn, NY
3The Bronx High School of Science, Bronx, NY
4Division of Hematology/Oncology, Brookdale University Hospital and Medical Center,, Long Beach, NY

Xinhe Shan, MD1, Edward A. Stadtmauer, MD2 and Sandra Susanibar-Adaniya, MD3

1Internal Medicine, Albert Einstein College of Medicine, Bronx, NY
2University of Pennsylvania, Philadelphia, PA
3Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Regina M. Myers, MD1, Sarah Mumanachit, MD2*, Shannon L. Maude, MD1, Amanda M. Dinofia, MD, MSCE1*, Jason L. Freedman, MD, MSCE1*, Nancy Bunin, MD1, Lisa Wray, MD1*, Allison Barz Leahy, MD, MSCE1, Timothy S Olson, MD, PhD3, Stephan Grupp, MD, PhD1, Alix E. Seif, MD, MPH1 and Caitlin W. Elgarten, MD1

1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
2Saint Jude Children's Research Hospital, Memphis, TN
3Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA

Anca Prica, MD1, Tiana Coley, BS2*, Rachel Aitken1*, Abi Vijenthira, MD, MS2, Manjula Maganti3*, Samantha J Mayo, PhD, RN4*, John Kuruvilla, MD, FRCPC2, Michael Crump, MD2*, Sita D. Bhella, MD2*, Robert Kridel2, Vishal Kukreti1, Chloe Yang, MD2*, Shabbir MH Alibhai, MD, MSc5* and Christine Chen, MHPE, MD, FRCPC2

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
2Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada
3Department of Biostatistics, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada
4Princess Margaret Cancer Centre, Lawrence S. Bloomberg Faculty of Nursing, Toronto, ON, CAN
5Department of Medicine, University Health Network, Toronto, CAN

Tarun Jain, MD1,2,3, Xu Ji, PhD, MSPH1,2,4*, Nicholas Degroote, MPH2*, Alexandra Himes, DO1*, Cortland Coxhead, MD1*, Anjali Khanna, MBBS, MPH1*, Alexandra Cathcart, MD1,2,3*, Tamara P. Miller, MD2,5, Kristie A. Blum, MD6, Keiko Tarquinio, MD1,7*, Ann C. Mertens, PhD, MS1,2,8* and Sharon M. Castellino, MD, MSc1,2

1Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
2Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
3Emory University Laney Graduate School, Atlanta, GA
4Department of Health Policy and Management, Emory University Rollins School of Public Health, Atlanta, GA
5Department of Pediatrics, Emory University School of Medicine, Decatur, GA
6Winship Cancer Institute of Emory University, Atlanta, GA
7Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA
8Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA

Asaad Trabolsi, MD1, Narendranath Epperla, MD, MS2, Kaitlin Annunzio, DO3, Dan Morgenstern Kaplan, MD, MSc4*, Peter Doukas, MD5*, Frederique St-Pierre, MD6, Brittany McCall, MD7*, Lindsey Fitzgerald, MD8, Sunwoo Han, PhD9*, Isildinha M. Reis, PhD10*, Jennifer Rose Chapman-Fredricks, MD11*, Khaled Alhamad, MD12*, Thomas Ollila, MD13, Reem Karmali, MD, MSc14, Izidore S. Lossos, MD15 and Juan Pablo Alderuccio, MD16

1Sylvester Comprehensive Cancer Center, University of Miami/ Jackson Memorial Hospital, Miami, FL
2Division of Hematology and Oncology, Medical College of Wisconsin, Columbus, OH
3Ohio State University Medical Center, Columbis, OH
4Internal Medicine Residency program, division of internal medicine, Department of Medicine, University of Miami/ Jackson Memorial Hospital, Miami
5Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
6Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
7Brown Medical School, Providence, RI
8Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
9Biostatistics and Bioinformatics Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
10Department of Public Health Sciences and Biostatistics and Bioinformatics Shared Resource, University of Miami Miller School of Medicine, Miami, FL
11Department of Pathology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
12University of Utah, Salt Lake City, UT
13Brown University, Providence, RI
14Northwestern University, Chicago, IL
15Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL
16Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Sandra CM Quinn, PhD, BA1*, Lauren Kelly, PhD, BSc2* and Tom Lewis, PhD, MSc, BSc2*

1Research and Advocacy, Myeloma UK, Edinburgh, SCO, United Kingdom
2Research and Advocacy, Myeloma UK, Edinburgh, United Kingdom

Alexander Vartanov, MD1, Jill S Hasler, PhD2*, Elizabeth Handorf, PhD2* and Zachary AK Frosch, MD, MSHP3

1Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA
2Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA
3Department of Hematology/Oncology; Cancer Prevention and Control Research Program, Fox Chase Cancer Center, Philadelphia, PA

Thomas Delea1*, Aaron Moynahan1*, Wenzhen Ge2*, Xue Song2*, Glenn S. Kroog2*, Irene Noguera-Troise2*, Karen Rodriguez Lorenc2 and Qiufei Ma2*

1Policy Analysis Inc., Boston, MA
2Regeneron Pharmaceuticals, Inc., Tarrytown, NY

Alissa Visram, MD, MPH1, Hsien Seow2*, Gregory Pond3*, Ana Gayowsky4*, Arleigh McCurdy, MD, BSc5, Christopher Cipkar, MD, BSc5*, Hyra Sapru, MD5, C. Tom Kouroukis, MD, MSc, FRCPC6, Mohammed Aljama, MBBS, FRCPC7*, Mohammad Ebraheem, MD8, Stephen Ronan Foley, MD9* and Hira Mian, MD8

1Division of Hematology, The Ottawa Hospital Research Institute, Ottawa, ON, Canada
2Department of Oncology, McMaster University, Hamilton, ON, Canada
3Escarpment Cancer Research Institute, McMaster University, Hamilton, ON, Canada
4Institute for Clinical Evaluative Sciences, McMaster University, Hamilton, ON, Canada
5The Ottawa Hospital, Ottawa, ON, Canada
6Juravinski Cancer Centre, Hamilton, On, CAN
7Juravinski Cancer Centre, Hamilton, ON, CAN
8McMaster University, Hamilton, ON, Canada
9Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada

Hans Lee, MD1, Sundar Jagannath, MD2, Devender Dhanda, PhD3*, Teofilia Acheampong, MPH, PhD3*, Pallavi Patwardhan, PhD, BSPharm3*, Thomas S. Marshall, PharmD3*, Suvina Amin, MPH3*, Tao Gu, PhD3* and Sikander Ailawadhi4

1The University of Texas MD Anderson Cancer Center, Houston, TX
2Mount Sinai Medical Center, New York, NY
3Bristol Myers Squibb, Princeton, NJ
4Mayo Clinic, Jacksonville, FL

Amy Y Wang, MD, MPH1, Annalynn M Williams, PhD, MS2, Yan Chen3*, Yutaka Yasui3*, Wendy Stock, MD4, Wendy Leisenring5*, Gregory Armstrong, MD3*, Kevin Oeffinger, MD6*, Eric J. Chow, MD7, Kevin R. Krull, PhD8* and Tara O. Henderson, MD9

1Northshore University HealthSystem, Evanston, IL
2University of Rochester, Rochester, NY
3St. Jude Children's Research Hospital, Memphis, TN
4Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
5Fred Hutchinson Cancer Center, Seattle, WA
6Duke University, Durham, NC
7Seattle Children's, Seattle, WA
8Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN
9University of Chicago Medical Center, Chicago, IL

Andrew J. Cowan, MD1, Krish Patel, MD2, Jakub Svoboda, MD3, Bijal D. Shah, MD4, Bruce D. Cheson5, Georges Azzi, MD6*, Viral Rabara, MD7*, Lori S. Muffly, MD8, Heidi Simmons, PhD9, Stephen Thuillier, PharmD10 and Jessica T. Leonard, MD11

1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
2Swedish Cancer Institute, Seattle, WA
3Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
4Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
5Lymphoma Research Foundation, New York, NY
6Sylvester Cancer Center, Miami, FL
7Carolina Blood and Cancer Care Associates, Rock Hill, SC
8Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA
9Adaptive Biotechnologies Corporation, Seattle, WA
10Adaptive Biotechnologies Corporation, Bothell, WA
11Department of Hematology & Medical Oncology, Oregon Health and Science University, Portland, OR

Naimisha Marneni, MBBS1*, Bhagirathbhai Dholaria, MBBS2, Salyka Sengsayadeth, MD3*, Eden Ayele Biltibo, MD, MS1, Vivek Patel, MD3, Shakthi Bhaskar, MD3, Reena Jayani, MD3, Jill Gilbert, MD1*, Jordan Berlin4*, Ashwin Kishtagari, MBBS5, Sanjay Mohan, MD, MSCI6, David Morgan, MD3*, Olalekan O. Oluwole, MBBS3, Bipin N. Savani, MD3, Adetola A. Kassim, MBBS, MS7 and Muhamed Baljevic, MD6*

1Vanderbilt University Medical Center, Nashville, TN
2Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
3Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
4Dept of Hematology/Oncology, Vanderbilt University Medical Center, Nashville
5Division of Hematology & Oncology, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Franklin, TN
6Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
7Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN

Wenqing Su1*, Melisa Stricherz2*, Alison Martin3*, Jonathan Belsey4*, Eric Kemadjou4* and Daniel J. DeAngelo5

1Jazz Pharmaceuticals, Philadelphia, PA
2Jazz Pharmaceuticals, Palo Alto, CA
3Crystallise Ltd, Stanford-le-Hope, Essex, United Kingdom
4JB Medical Ltd, Sudbury, Suffolk, United Kingdom
5Dana-Farber Cancer Institute, Boston, MA

Shayna R Sarosiek1, Gottfried von Keudell, MD, PhD2, Jonas Paludo, MD3, Monika Salkar, PhD4*, Barnabie Agatep, MPH5*, Anjali Franco, MD5*, Samuel Crawford, PhD4*, Michelle Pacia, PharmD, MBA4* and Jorge J. Castillo, MD6

1Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
2Harvard Medical School, Boston, MA
3Mayo Clinic, Rochester, MN
4AbbVie, North Chicago, IL
5Inovalon, Bowie, MD
6Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

Muhammad Saad Hamid, MD1, Claire Bai, MS2*, Chelsea Perelgut, BSN, RN2*, Helena Yelovich, MD2*, Christina M. Zettler2*, Laura L. Fernandes, PhD2*, Andrew J. Belli, MPH2*, Eric Hansen, MS2* and Ching-Kun Wang, MD2*

1Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, TN
2COTA, Inc., New York, NY

Yajur Arya, MD1,2, Arshi Syal, MD1,2*, Bruce Adrian Casipit, MD1,2*, Claudia Dourado, MD1,2, Ryan J Mayo, MD1,2* and Carlo Casipit, MD1,2*

1Albert Einstein Medical Center, Philadelphia, PA
2Thomas Jefferson University Hospital, Philadelphia, PA

Anmol Goyal, MD1*, Sushma Bharadwaj, MD, MS1, Dasom Lee, MD2*, Eric Lau, DO3, Mark P. Hamilton, MD4, Alexandria Jensen, PhD5*, Bita Sahaf, PhD, MSc6*, Shriya Syal, MS6*, Sunita Patil6*, Juancarlos E Cancilla6*, Theresa Latchford7*, Wen-Kai Weng, MD, PhD1, Melody Smith, MD, MS8, Matthew J. Frank, MD, PhD1, David B. Miklos, MD, PhD1 and Saurabh Dahiya1*

1Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
2Division of Hematology, Stanford University, Stanford
3Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Mountain View, CA
4Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
5Quantitative Sciences Unit, Stanford University, Palo Alto, CA
6Cancer Correlative Science Unit, Stanford University, Palo Alto, CA
7Stanford Health Care, Stanford, CA
8Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA

Kyle Kidwell, MD1, Rui Zhu, PhD1*, Susan Bal, MD1*, Kelly Godby, MD1*, Gayathri Ravi, MD1, Luciano Costa, MD, PhD1, Sadeep Shrestha, PhD2*, Grant Williams, MD1*, Smita Bhatia, MD, MPH1 and Smith Giri, MD, MS1*

1University of Alabama at Birmingham, Birmingham, AL
2School of Public Health, University of Alabama at Birmingham, Birmingham, AL

Sophia Lee, MD1,2, Supreet Kaur, MD1,3, Michael Mader, MS1,2*, Kathleen Franklin, RN2*, Madison Williams, MD4*, Ryan Williams, MD5*, Jean-Pierre Blaize, MD6*, Amna Naqvi, BS1,2*, Snegha Ananth, MBBS7, Michael Meansup Song, MD8*, Brian Warnecke, DO1,2*, Abhishek Pandya, DO1,2*, Lakene Raissa Djoufack Djoumessi, MD1,2*, Lindsey Lu, PharmD9*, Phillip Nazarewicz, BS2*, Manuel Espinoza-Gutarra, MD10*, Kana Tai Lucero, MD1,2*, Jennifer Whitehead, MS2*, Alaq Al-Abayechi, MD1,2*, Lauren Boyle, DO1,2*, Gabriel Roman Souza, MD1,2, Esteban Toro Velez, MD1, Ian Mines, DO1,11 and Zohra Nooruddin, MD1,2

1University of Texas Health-San Antonio, San Antonio, TX
2South Texas Veterans Health Care System, San Antonio, TX
3UT Health Cancer Center, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX
4University of Texas MD Anderson Cancer Center, Houston, TX
5University of Texas MD Anderson Cancer Center, Houston
6Augusta Oncology, Augusta, GA
7Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
8Baylor College of Medicine, Houston
9Palo Alto Veterans Affairs, Palo Alto, CA
10O'Neal Comprehensive Cancer Center at University of Alabama Birmingham, Birmingham, AL
11University of Texas Health Science Center at San Antonio, San Antonio, TX

Ravi Vij, MD, MBA1, Suvina Amin, MPH2*, Jin Gu, PhD2*, Thomas S. Marshall, PharmD2*, Susan Fish, MS2*, Sujith Dhanasiri, MSc3*, Gabriela Hernandez, MD3*, David Cella, PhD4*, Hartmut Goldschmidt5 and Karthik Ramasamy6

1Division of Oncology, Washington University School of Medicine, Saint Louis, MO
2Bristol Myers Squibb, New York, NY
3Celgene International Sàrl, a Bristol Myers Squibb Company, Boudry, Switzerland
4Northwestern University, Feinberg School of Medicine, Chicago, IL
5Internal Medicine V, GMMG - Study Group at University Hospital Heidelberg, Heidelberg, Germany
6Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Veit L. Buecklein, MD1,2,3*, Kai Rejeski, MD3,4,5,6, Ariel Perez, MD7*, Gloria Iacoboni, MD8*, Vindi Jurinovic, MSc9*, Soraya Kharboutli, MD10,11*, Viktoria Blumenberg, MD1,2,3,4, Josephine Ackermann2*, Lisa Frölich2*, Grace Johnson12*, Kedar Patel12*, Brian Arciola12*, Rahul Mhaskar12*, Christian Schmidt, MD2*, Anthony Wood, MD13*, Eva Hoster14*, Andreas Mackensen, MD10,11*, Frederick L. Locke, MD13, Michael von Bergwelt-Baildon, MD, PhD2,3,4*, Fabian Mueller, MD11,15*, Pere Barba, MD8, Michael D. Jain, MD, PhD13 and Marion Subklewe, MD4,5,15,16

1Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
2Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
3Bavarian Cancer Research Center (BZKF), Munich, Germany
4German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
5Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany
6LMU University Hospital, Munich, Germany
7Blood and Marrow Transplant Program, Miami Cancer Institute, Miami Cancer Institute, Baptist Health South Florida, Miami, FL
8Vall d’Hebron Institute of Oncology (VHIO), Department of Hematology, University Hospital Vall d'Hebron, Universitat Autònoma of Barcelona (UAB), Barcelona, Spain
9Institute of Medical Data Processing, Biometrics and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany
10Bavarian Cancer Research Center (BZKF), Erlangen, Germany
11Department of Internal Medicine 5, Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany
12University of South Florida Morsani College of Medicine, Tampa, FL
13Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
14Institute of Medical Data Processing, Biometrics and Epidemiology (IBE), LMU Munich, Munich, Germany
15Bavarian Cancer Research Center (BZKF), R/R ALL Study Group, Bavaria, Germany
16Department of Medicine III, LMU University Hospital, LMU Munich, Muenchen, Bavaria, Germany

Suma Sri Chennapragada, MD1, Shriya Goyal2*, Vaishnavi Singh, MD3,4*, Saloni Savani, MD5*, Sindhu Thevuthasan, MD6*, Kamleshun Ramphul, MD7*, Shivani Sharma, MBBS8, Arcita Hanjani Pramudita, MD9*, Hemamalini Sakthivel, MD10* and Poornima Ramadas, MD11,12

1LSUHSC-S/Feist-Weiller Cancer Center, Shreveport, LA
2LSU health shreveport, Shreveport
3Willis-Knighton Medical Center, Shreveport, LA
4Willis Knighton health system, Shreveport
5Wills Knighton Health System, Shreveport, LA
6LSU Health Shreveport, Shreveport, LA
7Independent Researcher, Triolet, Mauritius
8Assistant Professor Clinical of Internal Medicine, Louisiana State University Health Shreveport, Shreveport, LA
9Harvard Medical School/Dana-Farber Cancer Institute, Boston, MA
10One Brooklyn Health System/Interfaith Medical Center Program, Brooklyn, NY, USA., New York
11Feist-Weiller Cancer Center, LSU Health Shreveport, Shreveport, LA
12LSUHSC-S, Feist Weiller Cancer Center, Shreveport, LA

Edvan de Queiroz De Queiroz Crusoe, MD, PhD, MSc1, Glaciano Ribeiro, MD2*, Leila Perobelli, MD3*, Karla Zanella, MD4*, Emanuella Graciott Souza, MD5*, Renato Centrone, MD6*, Fabiana Higashi, MD7*, Rosane Bittencourt, MD8*, Fabio Moreno, MD9*, Joao Saraiva, MD10*, Roberto Pessoa Magalhaes Filho, MD11*, Fernanda Lemos Moura, MD12*, Lucas Oliveira Cantadori, MD13*, James Maciel, MD14*, Caroline Bonamin Sola, MD15*, Abrahão Elias Hallack Neto, MD, PhD16*, Danielle C. Ovigli Silva Lopes, MD17*, Cleder Aparecido Da Silva Da Silva Araujo, MD18*, Walter Moisés Tobias Braga, MD19*, Luciana Barreto Herriot, MD, MSc20*, Breno Gusmao, MD21*, Gracia Martinez, MD22*, Luiza Soares, MD23*, Jorge Vaz, MD24*, Angelo Maiolino25* and Vania T.M Hungria, MD26

1Hematology- Hemotherapy Unity, University Hospital from Federal University of Bahia, and Rede D'or Oncology, Salvador, Bahia, Brazil
2Clinica Hematologica, Belo Horizonte, BRA
3Hospital de Transplantes Euryclides de Jesus Zerbini / Hospital Brigadeiro, São Paulo, Brazil
4CEPON, Florianopolis, BRA
5University Hospital from Federal University of Minas Gerais, Belo Horizonte, BRA
6HEMOMED, Sas Paulo, BRA
7SANTA CASA DE SAO PAULO, SAO PAULO, BRA
8HC Porto Alegre, Porto Alegre, BRA
9Hospital do Cancer Mae de Deus, Porto Alegre, Porto Alegre, Brazil
10IHEBE, belem, Brazil
11Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
12A.C. Camargo Cancer Center, Sao Paulo, Brazil
13Hospital Das Clínicas UNESP, Botucatu, Brazil
14Liga Norte rio-grandense contra o câncer, Natal, BRA
15HC - UFPR, Curitiba, BRA
16Universidade Federal De Juiz De Fora, Juiz de Fora, BRA
17Hospital Israelita Albert Einstein, São Paulo, AL, BRA
18IPSEMG, Minas Gerais, Belo Horizonte, Brazil
19UNIFESP, Sao Paulo, Brazil
20INCA, Rio D Janeiro, BRA
21Beneficencia Portuguesa, Sao Paulo, BRA
22Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, BRA
23Universidade Federal do Alagoas, Maceio, Brazil
24CETTRO, Brasilia, Brazil
25Instituto Americas de Ensino,, Pesquisa e Inovacao, Rio de Janeiro, Brazil
26Department of Hematology, Clinica São Germano, São Paulo, Brazil

Sharon M. Castellino, MD, MSc1, Rebecca Williamson Lewis, MPH2*, Karen E Effinger, MD, MS2,3*, Ann C. Mertens, PhD, MS1,2*, Joseph Lipscomb, PhD4* and Xu Ji, PhD, MSPH5*

1Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
2Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
3Pediatric Hematology/Oncology, Emory University, Atlanta, GA
4Department of Health Policy and Management, Emory University Rollins School of Public Health, Atlanta, GA
5Emory University / Children's Healthcare of Atlanta, Atlanta, GA

Yoona Choi1,2*, Bo Kyung Kim, MD3,4*, Jae Won Yoo, MD5*, Wona Choi, PhD6*, Jung-Hyun Won2,7*, Surin Jung6*, Jae Yoon Kim6,8*, In Young Choi, PhD6*, Nack-Gyun Chung, MD, PhD9*, Jae Wook Lee, MD, PhD9*, Hyoung Jin Kang, MD, PhD3,4 and Howard Lee, MD, PhD2,7,10,11,12*

1Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Suwon-Si, South Korea
2Center for Convergence Approaches in Drug Development, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea, Republic of (South)
3Department of Pediatrics, Seoul National University College of Medicine and Hospital, Seoul, Korea, Republic of (South)
4Seoul National University Cancer Research Institute, Seoul, Korea, Republic of (South)
5Department of Pediatrics, College of Medicine, The Catholic University of Korea, SEOUL, Korea, Republic of (South)
6Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
7Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea, Republic of (South)
8Department of Biomedicine & Health Sciences, The Catholic University of Korea, Seoul, Korea, Republic of (South)
9Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
10Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Korea, Republic of (South)
11Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea, Republic of (South)
12Advanced Institutes of Convergence Technology, Suwon, Korea, Republic of (South)

Carlyn Rose Tan, MD1*, Nina Kim2*, Eric Chinaeke3*, Laura Hester4*, Jessica Fowler, PhD5*, Dina Gifkins6*, Dee Lin2*, Sian Walker7*, Alex Z. Fu3,8* and Bingcao Wu2*

1Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Janssen Scientific Affairs, LLC, Horsham, PA
3Janssen Scientific Affairs, LLC, Titusville, NJ
4Janssen R&D, LLC, Horsham, PA
5Johnson & Johnson, Horsham, PA
6Janssen R&D, LLC, Titusville, NJ
7Sierra Medical Affairs, LLC, Truckee, CA
8Georgetown University Medical Center, Washington, DC

Ziyad Alrajhi, MD1*, Adam Yan1, Etienne Sochett, MD2*, Reza Vali, MD3*, Amer Shammas, MD3*, Michelle Furman, BMSc2*, Emily Lam, MSc4*, Maria Locke, BA4* and Paul Nathan, MD1*

1Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada
2Department of Pediatrics, Division of Endocrinology, The Hospital for Sick Children, Toronto, Canada
3Department of Diagnostic Imaging, Division of Nuclear Medicine, The Hospital for Sick Children, Toronto, Canada
4Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Canada

Naveen Subramanian, MD1, Ashwath Gurumurthi, MBBS2*, Oren Pasvolsky, MD3,4,5*, Christopher Ferreri, MD6*, Hans Lee, MD7, Elisabet E. Manasanch, MD8, Sheeba K. Thomas, MD2, Donna M. Weber, MD2, Mahmoud Gaballa, MD2, Christen Dillard, MD9*, Melody Becnel, MD10, Chitra Hosing, MD4, Pei Lin, MD, DM, MDPC11, Behrang Amini, MD, PhD12*, Muzaffar H. Qazilbash, MD4, Nilesh Kalariya, PhD, RN2*, Misha Hawkins, MSN, RN9*, Sairah Ahmed, MD8, Robert Z. Orlowski, MD, PhD13 and Krina K. Patel, MD, MSc14

1Department of Internal Medicine, The University of Texas Health Sciences Center at Houston, Houston, TX
2Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
4Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
5Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
6MD Anderson Cancer Center, Houston
7Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
8Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
9The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston
11Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
12Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
13Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
14University of Texas MD Anderson Cancer Center, Houston, TX

Amna Naqvi, BS1*, Supreet Kaur, MD1,2, Michael Mader, MS1,2*, Kathleen Franklin, RN2*, Madison Williams, MD3*, Ryan Williams, MD3*, Jean-Pierre Blaize, MD4*, Snegha Ananth, MBBS1,2, Michael Meansup Song, MD5,6*, Brian Warnecke, DO1,2*, Abhishek Pandya, DO1,2*, Lakene Raissa Djoufack Djoumessi, MD1,2*, Lindsey Lu, PharmD7*, Phillip Nazarewicz, BS2*, Manuel Espinoza-Gutarra, MD8*, Kana Tai Lucero, MD1,2*, Jennifer Whitehead, MS2*, Alaq Al-Abayechi, MD1,2*, Lauren Boyle, DO1,2*, Sophia Lee, MD1, Gabriel Roman Souza, MD1,2, Esteban Toro Velez, MD1, Ian Mines, DO2,6 and Zohra Nooruddin, MD1,2

1University of Texas Health-San Antonio, San Antonio, TX
2South Texas Veterans Health Care System, San Antonio, TX
3University of Texas MD Anderson Cancer Center, Houston, TX
4Augusta Oncology, Augusta, GA
5Baylor College of Medicine, Houston
6University of Texas Health Science Center at San Antonio, San Antonio, TX
7Palo Alto Veterans Affairs, Palo Alto, CA
8O'Neal Comprehensive Cancer Center at University of Alabama Birmingham, Birmingham, AL

Evelyn Pamela Espinoza Morales, MBBS1*, Veronica Y Arnao-Labajos, MD2*, Juan Carlos Haro-Varas, MD2*, Bryan Valcarcel, MD, MPH3 and Daniel J Enriquez, MD4

1Universidad Privada San Juan Bautista, Lima, Peru
2Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
3The George Washington University, Washington, DC
4Kagoshima University, Kagoshima, Japan

Pia Glogowski1*, Léa Thérond1*, Tobias Giebler1*, Stefanie Thiel, MD1*, Johanna Sophie Xemaire, MSc2*, Christian Martin Seitz, MD, PhD1*, Johannes Schulte, MD, PhD1*, Peter Lang, MD, PhD1*, Rupert Handgretinger, MD, PhD1, Karin Melanie Cabanillas Stanchi, PhD, MSc3* and Michaela Döring, MD, PhD1*

1Dpt. I - General Pediatrics, Hematology and Oncology, University Children's Hospital Tübingen, Tübingen, Germany
2Tübinger Akademie für Kinder- und Jugendlichenpsychotherapie GmbH, Tübingen, Germany
3Dpt. I - General Pediatrics, Hematology and Oncology, University Children's Hospital Tübingen, Tübingen, GA, Germany

John Mariano, MD1, Hayley Brianne Flanagan, MD2, Kimberly H Seymour, MD, MS3, Nicole SanGiacomo, CPNP-AC, MSN, RN, CPHON3*, Nneka Ogbutor, MD1*, Arman Niknafs, BSc4, Brittany Hodges, BA1*, Adam Evans, MD1* and Jeffrey R. Andolina, MD, MS1

1University of Rochester Medical Center, Rochester, NY
2Internal Medicine-Pediatrics, University of Rochester Medical Center, Rochester, NY
3University of Rochester Medical Center, Rochester
4University of Rochester School of Medicine and Dentistry, Rochester, NY

*signifies non-member of ASH